Search Menu
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information
Search Scholarly Publications

Title: Structure, function, and inhibition of drug reactivating human gut microbial β-glucuronidases

Journal Article · · Scientific Reports
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1]
  1. Univ. of North Carolina, Chapel Hill, NC (United States)
+ Show Author Affiliations

Bacterial β-glucuronidase (GUS) enzymes cause drug toxicity by reversing Phase II glucuronidation in the gastrointestinal tract. While many human gut microbial GUS enzymes have been examined with model glucuronide substrates like p-nitrophenol-β-D-glucuronide (pNPG), the GUS orthologs that are most efficient at processing drug-glucuronides remain unclear. Here we present the crystal structures of GUS enzymes from human gut commensals Lactobacillus rhamnosus, Ruminococcus gnavus, and Faecalibacterium prausnitzii that possess an active site loop (Loop 1; L1) analogous to that found in E. coli GUS, which processes drug substrates. We also resolve the structure of the No Loop GUS from Bacteroides dorei. We then compare the pNPG and diclofenac glucuronide processing abilities of a panel of twelve structurally diverse GUS proteins, and find that the new L1 GUS enzymes presented here process small glucuronide substrates inefficiently compared to previously characterized L1 GUS enzymes like E. coli GUS. We further demonstrate that our GUS inhibitors, which are effective against some L1 enzymes, are not potent towards all. Our findings pinpoint active site structural features necessary for the processing of drug-glucuronide substrates and the inhibition of such processing.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH); National Cancer Institute (NCI)
OSTI ID:
1497166
Journal Information:
Scientific Reports, Journal Name: Scientific Reports Journal Issue: 1 Vol. 9; ISSN 2045-2322
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (53)

Enzyme Function Initiative-Enzyme Similarity Tool (EFI-EST): A web tool for generating protein sequence similarity networks journal August 2015
Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity journal September 2015
Drug Metabolism in the Liver journal February 2017
Integration of hepatic drug transporters and phase II metabolizing enzymes: Mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites journal April 2006
The gastrointestinal microbiota as a site for the biotransformation of drugs journal November 2008
An Atlas of β-Glucuronidases in the Human Intestinal Microbiome journal July 2017
Topoisomerase I inhibitors: camptothecins and beyond journal October 2006
Human gut-microbiome-derived propionate coordinates proteasomal degradation via HECTD2 upregulation to target EHMT2 in colorectal cancer journal January 2022
Carbohydrate-binding modules: fine-tuning polysaccharide recognition journal September 2004
Genetic characterization of the  -glucuronidase enzyme from a human intestinal bacterium, Ruminococcus gnavus journal July 2005
Pharmacologic Targeting of Bacterial β-Glucuronidase Alleviates Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy in Mice journal February 2012
Chemical transformation of xenobiotics by the human gut microbiota journal June 2017
Enzymatic Transition States, Transition-State Analogs, Dynamics, Thermodynamics, and Lifetimes journal July 2011
Combined Irinotecan and Oxaliplatin in Patients with Advanced Pre-Treated Pancreatic Cancer journal January 2004
Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ journal March 2013
A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption—Part I: Gastrointestinal pH journal August 2016
Pharmacology of irinotecan journal January 1998
Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics journal June 2013
Toxicological and pharmacokinetic analysis at therapeutic dose of SRS27, an investigational anti-asthma agent journal August 2020
Enzyme Function Initiative-Enzyme Similarity Tool (EFI-EST): A web tool for generating protein sequence similarity networks journal August 2015
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites journal June 2016
Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity journal September 2015
Drug Metabolism in the Liver journal February 2017
Bacteria as vitamin suppliers to their host: a gut microbiota perspective journal April 2013
Integration of hepatic drug transporters and phase II metabolizing enzymes: Mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites journal April 2006
The gastrointestinal microbiota as a site for the biotransformation of drugs journal November 2008
An Atlas of β-Glucuronidases in the Human Intestinal Microbiome journal July 2017
Gut Microbial β-Glucuronidase Inhibition via Catalytic Cycle Interception journal July 2018
Topoisomerase I inhibitors: camptothecins and beyond journal October 2006
The gut flora as a forgotten organ journal July 2006
Carbohydrate-binding modules: fine-tuning polysaccharide recognition journal September 2004
Glucuronides in the gut: Sugar-driven symbioses between microbe and host journal April 2017
Malectin: A Novel Carbohydrate-binding Protein of the Endoplasmic Reticulum and a Candidate Player in the Early Steps of Protein N -Glycosylation journal August 2008
Multiple NSAID-Induced Hits Injure the Small Intestine: Underlying Mechanisms and Novel Strategies journal October 2012
Genetic characterization of the  -glucuronidase enzyme from a human intestinal bacterium, Ruminococcus gnavus journal July 2005
Pharmacologic Targeting of Bacterial β-Glucuronidase Alleviates Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy in Mice journal February 2012
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme journal November 2010
Chemical transformation of xenobiotics by the human gut microbiota journal June 2017
Enzymatic Transition States, Transition-State Analogs, Dynamics, Thermodynamics, and Lifetimes journal July 2011
Combined Irinotecan and Oxaliplatin in Patients with Advanced Pre-Treated Pancreatic Cancer journal January 2004
Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ journal March 2013
Analysis of the substrate inhibition of complete and partial types journal June 2015
A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption—Part I: Gastrointestinal pH journal August 2016
Pharmacology of irinotecan journal January 1998
Using Sequence Similarity Networks for Visualization of Relationships Across Diverse Protein Superfamilies journal February 2009
Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics text January 2014
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme text January 2010
Glucuronides in the gut: Sugar-driven symbioses between microbe and host text January 2017
Pharmacologic Targeting of Bacterial  -Glucuronidase Alleviates Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy in Mice text January 2012
Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity text January 2015
Multiple NSAID-Induced Hits Injure the Small Intestine: Underlying Mechanisms and Novel Strategies text January 2013
Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics journal June 2013
Microbial degradation of complex carbohydrates in the gut journal July 2012

Cited By (2)

Microbiome Is a Functional Modifier of P450 Drug Metabolism journal October 2019
Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens journal October 2019

Similar Records

Related Subjects

60 APPLIED LIFE SCIENCES
Hydrolases
X-ray crystallography